Dionex (NASDAQ:DNEX) to Continue Strong Organic Growth

Dionex (NASDAQ:DNEX) is expected to continue their strong organic growth narrative, according to Jefferies (NYSE:JEF), citing their continued focus on liquid chromatography analytical technologies.

Jefferies said, "DNEX's core focus in liquid chromatography analytical technologies, success in penetrating adjacent market niches, effective cost structure management, and disciplined capital re-deployment history have contributed to above-average organic revenue growth and profitability profiles and superior ROIC."

EPS estimates for full year 2011 and 2012 were maintained at $3.70 and $4.15.

Jefferies reiterates their "Hold" rating on Dionex, which closed Tuesday at $117.82, down $0.01, or 0.01 percent. They raised their price target on them from $100 to $118.50.